» Articles » PMID: 29669571

Sex Differences in Pulmonary Arterial Hypertension: Role of Infection and Autoimmunity in the Pathogenesis of Disease

Overview
Journal Biol Sex Differ
Publisher Biomed Central
Specialties Biology
Physiology
Date 2018 Apr 20
PMID 29669571
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Registry data worldwide indicate an overall female predominance for pulmonary arterial hypertension (PAH) of 2-4 over men. Genetic predisposition accounts for only 1-5% of PAH cases, while autoimmune diseases and infections are closely linked to PAH. Idiopathic PAH may include patients with undiagnosed autoimmune diseases based on the relatively high presence of autoantibodies in this group. The two largest PAH registries to date report a sex ratio for autoimmune connective tissue disease-associated PAH of 9:1 female to male, highlighting the need for future studies to analyze subgroup data according to sex. Autoimmune diseases that have been associated with PAH include female-dominant systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, and thyroiditis as well as male-dominant autoimmune diseases like myocarditis which has been linked to HIV-associated PAH. The sex-specific association of PAH to certain infections and autoimmune diseases suggests that sex hormones and inflammation may play an important role in driving the pathogenesis of disease. However, there is a paucity of data on sex differences in inflammation in PAH, and more research is needed to better understand the pathogenesis underlying PAH in men and women. This review uses data on sex differences in PAH and PAH-associated autoimmune diseases from registries to provide insight into the pathogenesis of disease.

Citing Articles

RPL39 Was Associated With Sex Differences in Pulmonary Arterial Hypertension.

Wang H, Li L, Zhou G, Wang L, Wu Z Can Respir J. 2025; 2025:7139235.

PMID: 39957991 PMC: 11824382. DOI: 10.1155/carj/7139235.


Sex matters: the frequently overlooked importance of considering sex in computational models.

Burrowes K, Ruppage M, Lowry A, Zhao D Front Physiol. 2023; 14:1186646.

PMID: 37520817 PMC: 10374267. DOI: 10.3389/fphys.2023.1186646.


HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development.

Cook C, Craddock V, Ram A, Abraham A, Dhillon N Compr Physiol. 2023; 13(3):4659-4683.

PMID: 37358518 PMC: 10693986. DOI: 10.1002/cphy.c210049.


Vascular stiffening in aging females with a hypertension-induced HIF2A gain-of-function mutation.

Volkova E, Procell L, Kong L, Santhanam L, Gerecht S Bioeng Transl Med. 2023; 8(2):e10403.

PMID: 36925716 PMC: 10013765. DOI: 10.1002/btm2.10403.


Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan.

Tamura Y, Kumamaru H, Inami T, Matsubara H, Hirata K, Tsujino I JACC Asia. 2022; 2(3):273-284.

PMID: 36338395 PMC: 9627817. DOI: 10.1016/j.jacasi.2022.02.011.


References
1.
Klein S . The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev. 2000; 24(6):627-38. DOI: 10.1016/s0149-7634(00)00027-0. View

2.
West S, Killian P, Lawless O . Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis Rheum. 1981; 24(5):662-8. DOI: 10.1002/art.1780240506. View

3.
Dinser R, Frerix M, Meier F, Klingel K, Rolf A . Endocardial and myocardial involvement in systemic sclerosis--is there a relevant inflammatory component?. Joint Bone Spine. 2012; 80(3):320-3. DOI: 10.1016/j.jbspin.2012.10.009. View

4.
Clemson B, Miller W, Luck J, Feriss J . Acute myocarditis in fulminant systemic sclerosis. Chest. 1992; 101(3):872-4. DOI: 10.1378/chest.101.3.872. View

5.
Mair K, Johansen A, Wright A, Wallace E, MacLean M . Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol. 2013; 171(3):567-79. PMC: 3969073. DOI: 10.1111/bph.12281. View